Guizhou Yibai Pharmaceutical Co., Ltd. announced earnings results for the half year ended June 30, 2021. For the half year, the company announced sales was CNY 1,687.093 million compared to CNY 1,472.885 million a year ago. Operating income was CNY 202.762 million compared to CNY 144.528 million a year ago. Net income was CNY 171.069 million compared to CNY 121.012 million a year ago. Basic earnings per share from continuing operations was CNY 0.216 compared to CNY 0.153 a year ago.